Corrigendum: Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial.

Front Neurosci

Nutrition and Metabolic Disease Research Center, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Published: November 2022

[This corrects the article DOI: 10.3389/fnins.2022.901846.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707332	PMC
http://dx.doi.org/10.3389/fnins.2022.1085572	DOI Listing

Publication Analysis

corrigendum probiotic

probiotic supplementation

supplementation systemic

systemic inflammation

inflammation relapsing-remitting

relapsing-remitting multiple

multiple sclerosis

sclerosis randomized

randomized double-blind

double-blind placebo-controlled

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!